Article

Development of an in-house Quantitative ELISA for the Evaluation of Different Covid-19 Vaccines in Human

2022-01-21

Abstract excerpt

<h4>Purpose: </h4> Reliable serological assays are needed to understand the real impact of COVID-19. In order to compare the efficiency of different COVID-19 vaccines used in the National Vaccination Program in Tunisia, we have developed a quantitative in-house ELISA. <h4>Methods: </h4>: The ELISA is based on the ectodomain of the SARS-CoV-2 Spike Baculovirus recombinant protein. We have used a panel of 145 COVID-...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 832f6bd0-2742-5c34-b846-668c3c767815
DOI: 10.21203/rs.3.rs-1249600/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development of an in-house Quantitative ELISA for the Evaluation of Different Covid-19 Vaccines in HumanDOI 10.21203/rs.3.rs-1249600/v1Read

Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Elderly People Over 85 Years of Age in GreeceSemantic proximity Read

The COVID-19 pandemic: viral variants and vaccine efficacySemantic proximity Read

COVID-19 Case Numbers as a Function of Regional Testing Strategy, Vaccination Coverage, and Vaccine TypeSemantic proximity Read

Quantifying post-vaccination protective anti-SARS-CoV-2 IgG antibodies in blood and saliva with a fully automated, high throughput digital immunoassaySemantic proximity Read

Expert Review of Global Real-World Vaccine Effectiveness Against SARS-CoV-2Semantic proximity Read

Translational Virology - COVID-19, The Perfect ExampleSemantic proximity Read

Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and SafetySemantic proximity Read

A review of leading COVID-19 vaccines, the quest for immune protection, and its key challenges. Part 3: Covid-19 vaccines – Key challenges and translational scienceSemantic proximity Read

Determinants of early antibody responses to COVID-19 mRNA vaccines in exposed and naive healthcare workersSemantic proximity Read

Literature analysis of the efficacy of COVID-19 vaccinationsSemantic proximity Read

An Overview of Vaccine Development for COVID-19Semantic proximity Read

Immune variants of SARS-CoV-2 could be a significant challenge for developing a pan genotype-specific vaccine.Semantic proximity Read